Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.

  title={Biofilm matrix of Candida albicans and Candida tropicalis: chemical composition and role in drug resistance.},
  author={Mohammed A Al-Fattani and L. Julia Douglas},
  journal={Journal of medical microbiology},
  volume={55 Pt 8},
Matrix material was extracted from biofilms of Candida albicans and Candida tropicalis and analysed chemically. Both preparations contained carbohydrate, protein, hexosamine, phosphorus and uronic acid. However, the major component in C. albicans matrix was glucose (32%), whereas in C. tropicalis matrix it was hexosamine (27%). Biofilms of C. albicans were more easily detached from plastic surfaces by treatment with the enzyme lyticase (beta-1,3-glucanase) than were those of C. tropicalis… 

Figures and Tables from this paper

Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.

It is demonstrated that biofilm forming ability, structure and matrix composition are highly species dependent with additional strain variability occurring with C. parapsilosis.

Filamentous Non-albicans Candida Species Adhere to Candida albicans and Benefit From Dual Biofilm Growth

It is concluded that dual culture biofilm of C. albicans with C. tropicalis or C. dubliniensis offers a growth advantage for both NACS, and the growth and maintenance, but not initial establishment, of dual-species biofilms is likely facilitated by interspecies cell-cell adherence.

Hyphal content determines the compression strength of Candida albicans biofilms.

The results suggest that the hyphae-to-yeast ratio influences the compression strength of C. albicans biofilms, and that eDNA may influence biofilm integrity adversely.

Putative Role of β-1,3 Glucans in Candida albicans Biofilm Resistance

Results provide indirect evidence suggesting a role for glucans in biofilm resistance and present a strong rationale for further molecular dissection of this resistance mechanism to identify new drug targets to treat biofilm infections.

Characteristics of biofilm formation by Candida tropicalis and antifungal resistance.

Real-time reverse transcription-PCR quantification showed that sessile cells overexpressed ERG11 and MDR1 (coding for an efflux protein belonging to the major facilitator superfamily) may contribute to the fluconazole resistance of the C. tropicalis biofilm.

Antifungal Activity against Candida Biofilms

The association of Candida species with biofilm formation increases the therapeutic complexity of foreign body-related yeast infections, and a better description of the extent and role of yeast in biofilms may be critical for developing novel therapeutic strategies in the clinical setting.

Role of biofilm morphology, matrix content and surface hydrophobicity in the biofilm-forming capacity of various Candida species.

The combinatorial effect of increased filamentation, maximum matrix content and high hydrophobicity contributes to the enhanced biofilm-forming capacity of C. tropicalis.

Large-Scale Biochemical Profiling of the Candida albicans Biofilm Matrix: New Compositional, Structural, and Functional Insights

Besides generating a true “encyclopedic” catalog of individual moieties from each of the different macromolecular categories, results also provide important insights into structural and functional aspects of the fungal biofilm matrix, particularly the interaction between different components and the contribution of multiple matrix constituents to biofilm antifungal drug resistance.

In Vitro Biofilm Activity of Non-Candida albicansCandida Species

The existence of intrinsic activity differences amongst NCAC species, which could have important implications in terms of species relative virulence, are demonstrated.

The Significance of Lipids to Biofilm Formation in Candida albicans: An Emerging Perspective

This review summarizes the knowledge accumulated on the impact that alterations in phospholipids may have on the biofilm forming ability of C. albicans and may provide the requisite impetus to analyze lipids from a therapeutic standpoint in managing C.Albicans biofilms.



Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents.

Biofilms formed on two different types of polyvinyl chloride catheter, obtained from different manufacturers, showed differences in susceptibility to amphotericin B, suggesting that drug resistance may arise as a result of highly specific, surface-induced gene expression.

Biofilm formation by Candida species on the surface of catheter materials in vitro

A model system for studying Candida biofilms growing on the surface of small discs of catheter material is described and could be used for testing the efficacy of antifungal agents against biofilm cells.

Mixed species biofilms of Candida albicans and Staphylococcus epidermidis.

The findings suggest that fungal cells can modulate the action of antibiotics, and that bacteria can affect antifungal activity in mixed fungal-bacterial biofilms.

Extracellular polymer of Candida albicans: isolation, analysis and role in adhesion.

Results indicate that EP originates from the cell surface of C. albicans and that it contains the surface component(s), probably mannoprotein in nature, responsible for yeast adhesion.

Penetration of Candida Biofilms by Antifungal Agents

Although the presence of bacteria and bacterial matrix material undoubtedly retarded the diffusion of the antifungal agents, poor penetration does not account for the drug resistance of Candida biofilm cells, even in these mixed-species biofilms.

Candida biofilms and their role in infection.

Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.

It was demonstrated that expression of genes encoding both types of efflux pump were up-regulated during the course of biofilm formation and development, and antifungal susceptibilities of biofilms formed by a set of C. albicans mutant strains deficient in efflux pumps were investigated to determine their contribution to biofilm resistance.

Interactions between Candida Species and Bacteria in Mixed Infections

The clinical manifestations, and processes of adhesion and biofilm formation, are described for mixed-species infections, in particular those involving colonization of oral tissues and dental or medical prostheses by mixed communities of Candida and bacteria.

Production of extracellular matrix by Candida albicans biofilms.

It is suggested that production of matrix material could contribute to the resistance of biofilm cells to antifungal agents in vivo.